Minerva Neurosciences (NERV) Market Capitalization (2014 - 2026)
Minerva Neurosciences (NERV) Market Capitalization (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Minerva Neurosciences |
198.87 Mn |
198.87 Mn |
- |
| Date | Value |
|---|
| Jun 12, 2026 |
198.87 Mn |
| Jun 11, 2026 |
205.01 Mn |
| Jun 10, 2026 |
206.55 Mn |
| Jun 9, 2026 |
209.84 Mn |
| Jun 8, 2026 |
201.06 Mn |
| Jun 5, 2026 |
217.75 Mn |
| Jun 4, 2026 |
209.84 Mn |
| Jun 3, 2026 |
205.45 Mn |
| Jun 2, 2026 |
206.33 Mn |
| Jun 1, 2026 |
215.11 Mn |
| May 29, 2026 |
215.55 Mn |
| May 28, 2026 |
219.50 Mn |
| May 27, 2026 |
230.92 Mn |
| May 26, 2026 |
229.16 Mn |
| May 22, 2026 |
230.92 Mn |
| May 21, 2026 |
241.01 Mn |
| May 20, 2026 |
222.14 Mn |
| May 19, 2026 |
191.41 Mn |
| May 18, 2026 |
210.50 Mn |
| May 15, 2026 |
228.72 Mn |
